Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study

Fig. 4

Prognostic outcomes of transplantation. A Relapse-free survival (RFS) in different donor type groups. B Overall survival in different donor type groups. C GvHD, Relapse-free survival in different donor type groups. D Overall survival in the aged < 60y and ≥ 60y cohorts. E RFS and cumulative incidence of relapse across the R/R and non-R/R cohort. F RFS and cumulative incidence of relapse across the low cytogenetic risk and higher cytogenetic risk cohort

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512